Emerging Novel Coronavirus (2019-nCoV) - Current Scenario, Evolutionary Perspective Based on Genome Analysis and Recent Developments
Affiliations
- PMID: 32036774
- DOI: 10.1080/01652176.2020.1727993
Abstract
Coronaviruses are the well-known cause of severe respiratory, enteric and systemic infections in a wide range of hosts including man, mammals, fish, and avian. The scientific interest on coronaviruses increased after the emergence of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) outbreaks in 2002-2003 followed by Middle East Respiratory Syndrome CoV (MERS-CoV). This decade's first CoV, named 2019-nCoV, emerged from Wuhan, China, and declared as "Public Health Emergency of International Concern" on January 30th, 2020 by the World Health Organization (WHO). As on February 4, 2020, 425 deaths reported in China only and one death outside China (Philippines). In a short span of time, the virus spread has been noted in 24 countries. The zoonotic transmission (animal-to-human) is suspected as the route of disease origin. The genetic analyses predict bats as the most probable source of 2019-nCoV though further investigations needed to confirm the origin of the novel virus. The ongoing nCoV outbreak highlights the hidden wild animal reservoir of the deadly viruses and possible threat of spillover zoonoses as well. The successful virus isolation attempts have made doors open for developing better diagnostics and effective vaccines helping in combating the spread of the virus to newer areas.
Keywords: 2019-nCoV; Coronavirus; Middle East Respiratory Syndrome CoV; Public Health Emergency; Severe Acute Respiratory Syndrome CoV; genetic analyses; reservoir host; therapeutics; vaccines; zoonoses.
Similar articles
- Overlapping and Discrete Aspects of the Pathology and Pathogenesis of the Emerging Human Pathogenic Coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoVJ Liu et al. J Med Virol. PMID 32056249. - ReviewFirst reported from Wuhan, PR China, on 31 December 2019, the ongoing outbreak of a novel coronavirus (2019-nCoV) causes great global concerns. Based on the advice of the …
- Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus FusionCM Coleman et al. J Virol 90 (19), 8924-33. PMID 27466418.Both SARS-CoV and MERS-CoV are zoonotic infections, with bats as the primary source. The 2003 SARS-CoV outbreak began in Guangdong Province in China and spread to humans …
- Receptor Recognition by Novel Coronavirus From Wuhan: An Analysis Based on Decade-Long Structural Studies of SARSY Wan et al. J Virol. PMID 31996437.Recently a novel coronavirus (2019-nCoV) has emerged from Wuhan, China, causing symptoms in humans similar to those caused by SARS coronavirus (SARS-CoV). Since SARS-CoV …
- Genomic Characterisation and Epidemiology of 2019 Novel Coronavirus: Implications for Virus Origins and Receptor BindingR Lu et al. Lancet. PMID 32007145.National Key Research and Development Program of China, National Major Project for Control and Prevention of Infectious Disease in China, Chinese Academy of Sciences, Sha …
- The Relationship of Severe Acute Respiratory Syndrome Coronavirus With Avian and Other CoronavirusesMW Jackwood. Avian Dis 50 (3), 315-20. PMID 17039827. - ReviewIn February 2003, a severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in humans in Guangdong Province, China, and caused an epidemic that had severe impact …
No hay comentarios:
Publicar un comentario